I'm sure these 30 pages of abstracts have multiple trials needing followup. What EXACTLY is your doctor and stroke hospital doing to facilitate that? Or are they both just HAVING THEIR HEADS UP THEIR FUCKING ASSES DOING NOTHING? Suggested followup bolded in red.
I'm looking forward to which is better caffeinol or nanocoffee?
http://www.ingentaconnect.com/contentone/cog/ct/2017/00000026/A00104s1/art00001?crawler=true&mimetype=application/pdf
Presidential Symposium:
How Efficient Is Clinical Translation in Neurology?
Modulating the Inflammation-Associated Stroke Vasculome
With Human Endothelial Progenitor Cells
Higher Cognitive Abilities Prior to Stroke Influence
Neuroplasticity and Mobilization of Human Bone Marrow
Stem Cells in Affording Neuroprotection
Mesenchymal Stem Cell-Derived Exosomes Mediate
Neurovascular Protection
Proof of Concept—CRISPR-Cas9 Lipid Nanoparticles as an
Efficient Delivery Tool for Cultured Cells and in Animal Models
KDEL Receptors—Novel ER Stress Response Genes
Age-Dependent Remodeling and Gene Expression Changes
of the Cerebral Pial Collaterals Following Traumatic Brain Injury
The Tricyclic Antidepressant Medication Nortriptyline Inhibits
-Synuclein Accumulation, Aggregation, and Toxicity in Multiple
In Vitro and In Vivo Models
LRRK2 Pathways: Relevance for Inherited and
Sporadic Parkinson’s Disease
Mitochondrial Unfolded Protein Response (mtUPR) Dysfunction
During the Progression of Alzheimer’s Disease
Complementation of
Lmx1a/Pitx3
-Null Embryos With Porcine
Blastomeres Generates Chimeric Fetal Porcine Brain
Nanocoffee Displays Neuroprotective Effects in Traumatic Brain
Injury Models
Allele-Specific Silencing of Mutant Huntingtin Gene Following
Injection of Complexed Lipid Nanoparticle and Transcription
Activator-Like Effectors In Vivo
Targeted Gene Regulation in Genetically Linked Neurological
Disorders Using CRISPR/Cas9 and Transcription Activator-Like
Effectors
Human Cord Blood Plasma as a Potential Therapeutic for ALS
Potential Repair of the Blood–Spinal Cord Barrier Coincides
With Reduction of Microhemorrhages in the Spinal Cord of
Symptomatic ALS Mice After Intravenous Human Bone Marrow
CD34
+
Cell Transplantation
Liposomes as Ang-(1–7) Carriers to the CNS for Ischemic
Stroke
Therapy
Inhibition of Drp1 Mitochondrial Translocation Provides Neural
Protection in Dopaminergic System in a Parkinson’s Disease
Model Induced by MPTP
Targets for Global Brain Delivery of Recombinant Protein
Histological Correlates of Traumatic Brain Injury-Induced
Anxiety Behaviors: A Target for Hyperbaric Oxygen Therapy
ECM Hydrogel Injection for the Treatment of Stroke
Improving Viability of hNSCs by Optimizing Biomechanical
Stresses During Cell Injection
The Synaptic Scaffolding Protein Homer1c Is Necessary for
Successful Learning and Memory and for Induction of Group 1
Metabotropic Glutamate Receptor-Mediated Long-Term
Depression
Nonhuman Primate Modeling of Zika Virus Vertical Transmission
Phase 1/2a Study to Evaluate the Safety of Neural Stem Cells
in Patients With Parkinson’s Disease
Investigating a Role for Connexin 43 in Hippocampal
Neurogenesis Following Moderate Traumatic Brain Injury
Astaxanthin Modulates Cognitive Function
in
Young and
Aged Mice
Hyperbaric Oxygen Therapy Effects on Traumatic Brain Injury-
Associated Behavioral Impairments
LISPRO, an Ionic Cocrystal of Lithium, Mitigates Alzheimer-Like
Pathological Changes in the Mice
Interrogating the Role of Peripheral-Derived Hematopoietic Cells
in Tissue Homeostasis Following Brain Trauma
Cerebral Aneurysm Healing: MCP-1–IL-6–OPN Pathway
Proteomic Comparison of Aged and Young Microglia Highlights
Biological Consequences of Aging
Modulation of Microglia Cannabinoid Receptor 2 to Ameliorate
Neuroinflammation in Parkinson’s Disease
A Nonhuman Primate Model Facilitates the Development
of Neuroplasticity-Related Treatment Targets for Anxiety
and Depressive Disorders
The Role of Maternal Gut Microbiome in Perinatal
Neurodevelopment: Implications for Neurodevelopmental
Disorders
Absence of Direct Cell-to-Cell Contact in Human iPSC-Induced
Neuroprotection Against Stroke In Vitro Reveals Novel Stem Cell
Anti-Inflammatory Secreted Factors and Filopodia Extension
Neural Stem Cell-Encoded Hypoxia Inducible Factor-1a
(HIF-1a)
Is Essential for the Endogenous Regenerative Response to
Ischemic Injury in a Mouse Model of Stroke
Postinjury Therapeutic Effects of 3,6
-Dithio Pomalidomide on
Traumatic Brain Injury
Zika Virus Dysregulates Gene Expression and Alters Protein
Secretion in Neural Stem Cells
Priming Effects of Endotoxemia on Neutrophil Activation,
Neuroinflammation, and Reperfusion Injury Following Transient
Global Ischemia
No comments:
Post a Comment